Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy
Meijin Huang,1 Jie Zhong,2 Chunlei Lu,1 Fenglian Deng,1 Li Li,1 Yixi Nong,1 Liudan Liang,1 Houji Qin,1 Yibin Deng3 1Department of Infectious Diseases, Affiliated Hospital of Youjiang Nationalities Medical College, Baise City, Guangxi Province, People’s Republic of China; 2Department of Neu...
Saved in:
Main Authors: | Huang M (Author), Zhong J (Author), Lu C (Author), Deng F (Author), Li L (Author), Nong Y (Author), Liang L (Author), Qin H (Author), Deng Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015) -
Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
by: Zhang C, et al.
Published: (2016) -
Hepatitis C virus genotypes: A plausible association with viral loads
by: Salma Ghulam Nabi, et al.
Published: (2013) -
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
by: Hans Ludger Tillmann
Published: (2008) -
Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients
by: Chenliang Zhou, et al.
Published: (2017)